Skip to main navigation
  • News
  • Alerts
  • Careers
  • Contact
Cidara Therapeutics, Inc.Cidara Therapeutics, Inc.
  • About
    • About Cidara
    • Management Team
    • Board of Directors
    • Partnership Inquiries
    • Careers
  • Pipeline
  • Rezafungin
    • Overview
    • Treatment
    • Prophylaxis
  • Cloudbreak
    • Overview – Antivirals
  • Publications
    • Rezafungin for IFD
    • Rezafungin – Other
    • Cloudbreak
  • Investors

    Secondary Investor Relations

    • Overview
    • Financials
    • Stock Information
    • Corporate Governance
    • News Releases
    • Events and Presentations
    • Analyst Coverage
    • Shareholder Services
Press enter to begin your search
  • Home
  • About
  • Drug Candidates
    • Pipeline
    • CD101 IV
    • CD101 Topical
    • C001
    • Publications
  • Cloudbreak
  • Opportunity
    • Systemic Fungal Infections
    • Systemic Candida Infections
    • Recurrent Vulvovaginal Candidiasis
    • Invasive Aspergillosis
  • Investors

    Secondary Investor Relations

    • Overview
    • Financials
    • Stock Information
    • Corporate Governance
    • News Releases
    • Events and Presentations
    • Analyst Coverage
    • Shareholder Services
  • Contact

10-Q

SEC Filings

Document Details

Form
10-Q
Filing Date
05/09/19
Document Date
03/31/19
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Cidara Therapeutics, Inc.
Issuer
Cidara Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

NAVIGATION

  • Overview
  • Financials
    • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Historical Lookup
    • Investment Calculator
  • Corporate Governance
    • Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
  • News Releases
  • Events and Presentations
    • Event Calendar
    • Past Events
  • Analyst Coverage
  • Shareholder Services
    • Investor FAQs
    • Information Request
    • E-mail Alerts
    • Investor Contact

Tool Kit

Print Page Print Page
RSS Feeds RSS Feeds
E-mail Alerts E-mail Alerts
Get Important News and Updates by Email Subscribe

About Cidara

Cidara is a clinical-stage biotechnology company focused on developing new anti-infectives and immunotherapies that have the potential to transform the standard of care and save or improve patients' lives.
Learn more >>

Recent News

Cidara Therapeutics to Present at Two Upcoming Medical Conferences
December 3, 2019
Cidara Therapeutics Named a San Diego Metro Area Top Workplace for the Third Consecutive Year
November 18, 2019
Cidara Provides Corporate Update and Reports Third Quarter 2019 Financial Results
November 7, 2019

Navigation

Secondary Investor Relations

  • Overview
  • Financials
  • Stock Information
  • Corporate Governance
  • News Releases
  • Events and Presentations
  • Analyst Coverage
  • Shareholder Services

Contact Us

Cidara Therapeutics, Inc.
6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121
Tel: (858) 752-6170
Email: info@cidara.com

© 2019 Cidara Therapeutics, Inc. | Terms of Use | Privacy Policy

Quick Links

Secondary Investor Relations

  • Overview
  • Financials
  • Stock Information
  • Corporate Governance
  • News Releases
  • Events and Presentations
  • Analyst Coverage
  • Shareholder Services

Tweets by @CidaraThera